Cancer treatment is getting smarter by using several methods at once. One exciting tool is graphene-based nanomaterials (GBNs). These tiny powerhouses can do three amazing things: deliver drugs, fix faulty genes, and cook cancer cells with heat. That's multitasking at its best! Graphene, graphene o
Did you know that people with disabilities are more likely to get cancer? Yet, they often can't join cancer clinical trials. Why? Because of rules that measure how well a person can perform daily activities, called performance status. This is set to make sure trial participants aren't too sick. But
Exercise is great for the body, especially the liver. It cuts down on stress that oxidizes (takes away oxygen from) cells. Scientists think a protein called irisin might be behind this benefit. In a study, mice got irisin injections or did endurance exercises for 8 weeks. Researchers looked at how t
Scientists have been looking into a particular protein called SUMO activating enzyme subunit 1, often shortened as SAE1. They want to understand its role in breast cancer. Using advanced computer-based studies and lab experiments, researchers found that SAE1 might speed up the growth of cancer cells
Breast cancer treatment is complicated, needing tailored care from teams of specialists. Studies show that rural patients often receive different treatments, like mastectomies, compared to city dwellers. This difference isn't always due to the disease getting worse or medical need. A recent study lo
Breast cancer tops the list of common cancers among women worldwide, with about two million new cases each year. To catch it early and save lives, many countries have set up regular breast cancer screening programs based on age. Now, experts are excited about using risk-adjusted screening, which con
Scientists in Tehran have been digging into the mysteries of breast cancer. They've been looking at something called the BRCA1 gene and a protein named CA15-3. By collecting samples from patients with breast cancer, they found that a significant portion, about a quarter, had an active BRCA1 gene. Th
When the COVID-19 pandemic hit in 2020, it threw a wrench into the world of sports, forcing athletes to adapt to strict lockdown rules. For German cross-country skiers, this meant finding creative ways to keep training despite the challenges. Instead of following the usual routines, they had to get
Early-stage breast cancer patients with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) tumors face a big challenge: disease recurrence. This kind of cancer is diverse and tricky to manage because a quarter of these patients will see their disease come b
Immunotherapy has been making waves in the treatment of esophageal cancer, especially when used after initial chemoradiation. But what about patients with esophageal squamous cell carcinoma who've had a different combo—immunochemotherapy before surgery? Does adjuvant immunotherapy (AIT) still matter
